The radiolabeled somatostatin analog [177Lu]Lu-DOTA-TATE has proven valuable for the treatment of SSTR2-expressing neuroendocrine cancers [8,10]. The gene discussed is SSTR2; the disease is neuroendocrine carcinoma.